Human Organoids Market Outlook:
Human Organoids Market size was over USD 1.15 billion in 2025 and is poised to exceed USD 6.28 billion by 2035, witnessing over 18.5% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of human organoids is evaluated at USD 1.34 billion.
Key Human Organoids Market Insights Summary:
Regional Highlights:
- Asia Pacific human organoids market holds the largest share by 2035, driven by rising demand for organ transplants and chronic diseases.
- North America market projects lucrative growth during the forecast timeline, driven by high R&D investment and commercialization of organoids.
Segment Insights:
- The kidney segment in the human organoids market is anticipated to hold the largest share by 2035, driven by the growing volume of kidney transplants globally.
- The biotech & pharma segment in the human organoids market is anticipated to hold a significant share by 2035, influenced by drug discovery focus using organoids derived from patient tissues.
Key Growth Trends:
- Increasing number of organ transplantation procedures
- Rising number of experiments in genetic science
Major Challenges:
- Increasing number of organ transplantation procedures
- Rising number of experiments in genetic science
Key Players: BioVT LLC, Thermo Fisher Scientific Inc., Corning Incorporated, Emulate Bio, Organovo Holdings Inc., Zen-Bio Inc, Hurel Corporation, Cellink AB, Biopredic International.
Global Human Organoids Market Forecast and Regional Outlook:
Market Size & Growth Projections:
- 2025 Market Size: USD 1.15 billion
- 2026 Market Size: USD 1.34 billion
- Projected Market Size: USD 6.28 billion by 2035
- Growth Forecasts: 18.5% CAGR (2026-2035)
Key Regional Dynamics:
- Largest Region: Asia Pacific
- Fastest Growing Region: Asia Pacific
- Dominating Countries: United States, China, Germany, Japan, United Kingdom
- Emerging Countries: China, Japan, India, South Korea, Singapore
Last updated on : 8 September, 2025
The market growth can be attributed to the rising incidence of infectious diseases worldwide. According to the Texas Biomedical Research Institute, infectious diseases kill more than 17 million people every year, and 30 new diseases have emerged in the last 20 years. Organoids are proven to be transformative novel tools for the study of human infectious diseases. For instance, lung organoids have been utilized to study respiratory viral infections such as SARS-CoV-2. Researchers are extensively using organoids to study mechanisms of diseases acting within human tissues.
Additionally, the rising demand for biobanking and tumor modeling is expected to propel market growth during the assessed time. According to the Orfonline Research Observation report, there were 340 operational biobanks present globally in 2023. Tumor organoid biobanks are considered to be a new platform for medical research. Also, the biobank of organoids allows scientists to gain access to standardized protocols for the fabrication of human organoids. Human organoids may also be deployed for the customization of therapy or personalized medicine.
Human Organoids Market Growth Drivers and Challenges:
Growth Drivers
-
Increasing number of organ transplantation procedures: The number of donors is much less than the number of people who need organ transplantation. According to data published by Penn Medicine in 2023, more than 100,000 people are waiting for transplantation in the U.S. Organoids are considered an alternative cell source for tissue engineering and aim to overcome the shortage of donors. These organoids are also helpful in drug testing of transplantation therapy.
- Rising number of experiments in genetic science: Organoids are used as a tool to study gene function and cell development. The technology is used in investigating gene roles and studying cell development and functions. According to the World Economic Forum in April 2024, a USD 3.1 billion research program in the U.S. has already identified more than 275 million genetic variants that could help in creating health equity. Moreover, preclinical drug testing of regenerative medicines uses human organoids in biomedical research.
Challenges
-
Inadequate infrastructure for 3D cell culture: The availability of the necessary equipment to use advanced techniques is one of the prerequisites for conducting 3D cell culture-based research. Moreover, deploying the equipment and infrastructure of 3D cell culture demands huge capital and time.
-
Difficulty in incorporating human organoids in workflows: The utility of the organoids is tempered by a variety of limitations such as limited maturation, and lack of high-fidelity cell types. Also, lack of standardization and variability in tissue sampling methods introduce challenges in organoid cultures.
Human Organoids Market Size and Forecast:
| Report Attribute | Details |
|---|---|
|
Base Year |
2025 |
|
Forecast Period |
2026-2035 |
|
CAGR |
18.5% |
|
Base Year Market Size (2025) |
USD 1.15 billion |
|
Forecast Year Market Size (2035) |
USD 6.28 billion |
|
Regional Scope |
|
Human Organoids Market Segmentation:
Product Segment Analysis
The kidney segment is estimated to gain the largest human organoids market share over the projected time frame attributed to the increasing number of kidney transplants performed globally as compared to other procedures. According to the American Kidney Fund, currently, there are more than 92,000 people on the national transplant list waiting for a kidney. Moreover, there has been a significant growth in kidney-related diseases which is projected to contribute to the segment growth. National Kidney Foundation states that currently 10% of the population globally is affected by chronic kidney disease. Organoid transplantation promotes the formation of target mesangial and pericyte cells in kidney organoids.
End-user Segment Analysis
The biotech & pharma industry segment in human organoids market is expected to garner a significant share on the back of rising focus on developing new drugs. In 2022, the Center for Drug Evaluation and Research approved 37 novel drugs as new therapeutic biological products. Organoids are replicated from the patient's tissue that simulate the response to radiation therapy and have the potential to act as biomarkers. Organoids have garnered remarkable attention in drug discovery due to their potential to revolutionize the drug development process.
Our in-depth analysis of the global human organoids market includes the following segments:
|
Product |
|
|
End user |
|
Vishnu Nair
Head - Global Business DevelopmentCustomize this report to your requirements — connect with our consultant for personalized insights and options.
Human Organoids Market Regional Analysis:
Asia Pacific Market Insights
The Asia Pacific human organoids market is projected to hold the largest market share by the end of 2035. The growth of the market can be attributed majorly to the rising need for organ transplantation and donation. According to the National Institutes of Health in 2022, 453.3 million people were suffering from chronic kidney disorders across southern, eastern and southern eastern regions of Asia. Furthermore, rising cases of infectious disease in the region are expected to boost the market growth.
In India, the market is expected to register rapid growth during the forecast period owing to rising incidence of cancer, government initiatives to promote human organoids, and supportive regulations for the development and commercialization of advanced human organoid products. Moreover, rising investments in gene mutation and cancer research and rapid adoption of advanced technologies are expected to fuel market growth in India going ahead.
North America Market Insights
The human organoids market in North America is projected to offer lucrative growth opportunities due to rising investment in research and development activities and the presence of robust healthcare and research facilities. The National Science Foundation stated that in the U.S., investment in R&D reached USD 886 billion in 2022. Also, there is commercialization of organoid models and stem cell research. In Canada, researchers are using cerebral organoids to treat neurological diseases. In March 2024, Sinai Health infused USD 10 million in funding to fuel the creation of lab-grown organoids for drug discovery.
Human Organoids Market Players:
- BioVT LLC
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Thermo Fisher Scientific Inc.
- Corning Incorporated
- Emulate Bio
- Organovo Holdings Inc.
- Zen-Bio Inc
- Hurel Corporation
- Cellink AB
- Biopredic International
The competitive landscape of the human organoids market is rapidly evolving as established key players, healthcare giants and new entrants are investing in drug development. Key players in the market are focused on developing new technologies and products catering to the stringent regulatory norms and consumer demand. These key players are adopting several strategies such as mergers and acquisitions, joint ventures, partnerships, and novel product launches to enhance their product base and strengthen their market position. Here are some key players operating in the global human organoids market:
Recent Developments
- In January 2025, MilliporeSigma joined hands with Opentrons Labworks, Inc. to fabricate and verify the platform utilizing the broad offering of automation-enabled assays. Customers will be able to place orders for workstations from mid-2025.
- In June 2024, Atelerix Ltd. and DefiniGEN Ltd announced the successful shipment of in vitro liver models to top-tier pharma customers in the U.S. These laboratories created liver models that mimic the natural behavior of the liver in the human body.
- Report ID: 3240
- Published Date: Sep 08, 2025
- Report Format: PDF, PPT
- Get detailed insights on specific segments/region
- Inquire about report customization for your industry
- Learn about our special pricing for startups
- Request a demo of the report’s key findings
- Understand the report’s forecasting methodology
- Inquire about post-purchase support and updates
- Ask About Company-Level Intelligence Additions
Have specific data needs or budget constraints?
Inquiry Before BuyingFrequently Asked Questions (FAQ)
Human Organoids Market Report Scope
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Connect with our Expert
Copyright @ 2025 Research Nester. All Rights Reserved.
